Connection

Benjamin Planquette to Humans

Back to Details
This is a "connection" page, showing publications Benjamin Planquette has written about Humans.
Benjamin Planquette
Connection Strength
0.055
Humans
  1. Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study. Thromb Res. 2021 01; 197:94-99.
    View in: PubMed
    Score: 0.007
  2. Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment. Eur Respir J. 2018 11; 52(5).
    View in: PubMed
    Score: 0.006
  3. Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality. Arthritis Rheumatol. 2021 11; 73(11):1976-1985.
    View in: PubMed
    Score: 0.002
  4. Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission. Eur Respir J. 2021 Jul; 58(1).
    View in: PubMed
    Score: 0.002
  5. Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost. 2021 07; 19(7):1823-1830.
    View in: PubMed
    Score: 0.002
  6. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance. Angiogenesis. 2021 08; 24(3):407-411.
    View in: PubMed
    Score: 0.002
  7. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study. Arch Cardiovasc Dis. 2021 May; 114(5):381-393.
    View in: PubMed
    Score: 0.002
  8. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study. J Am Heart Assoc. 2021 04 20; 10(8):e018624.
    View in: PubMed
    Score: 0.002
  9. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 08; 24(3):505-517.
    View in: PubMed
    Score: 0.002
  10. Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells. Stem Cell Rev Rep. 2021 04; 17(2):639-651.
    View in: PubMed
    Score: 0.002
  11. Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood. 2020 11 12; 136(20):2290-2295.
    View in: PubMed
    Score: 0.002
  12. Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thromb Haemost. 2020 09; 18(9):2391-2399.
    View in: PubMed
    Score: 0.002
  13. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020 11; 23(4):611-620.
    View in: PubMed
    Score: 0.002
  14. A pilot experience of common European infectious diseases curriculum for medical students: the IDEAL summer school. Future Microbiol. 2019 03; 14:369-372.
    View in: PubMed
    Score: 0.002
  15. Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2019 03 14; 40(11):902-910.
    View in: PubMed
    Score: 0.002
  16. Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. Eur Heart J. 2018 12 14; 39(47):4196-4204.
    View in: PubMed
    Score: 0.002
  17. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data. BMJ Open. 2018 11 28; 8(11):e023939.
    View in: PubMed
    Score: 0.002
  18. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems. Thromb Res. 2018 11; 171:97-102.
    View in: PubMed
    Score: 0.002
  19. Determinants and prognostic implication of diagnostic delay in patients with a first episode of pulmonary embolism. Thromb Res. 2018 11; 171:190-198.
    View in: PubMed
    Score: 0.002
  20. Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial. Eur Respir J. 2018 01; 51(1).
    View in: PubMed
    Score: 0.001
  21. Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism. Eur Respir J. 2017 Dec; 50(6).
    View in: PubMed
    Score: 0.001
  22. Risk factors of occult malignancy in patients with unprovoked venous thromboembolism. Thromb Res. 2017 Nov; 159:48-51.
    View in: PubMed
    Score: 0.001
  23. Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism. PLoS One. 2017; 12(6):e0178849.
    View in: PubMed
    Score: 0.001
  24. Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism. Thromb Res. 2017 Jul; 155:6-9.
    View in: PubMed
    Score: 0.001
  25. Pulmonary embolism related sudden cardiac arrest admitted alive at hospital: Management and outcomes. Resuscitation. 2017 06; 115:135-140.
    View in: PubMed
    Score: 0.001
  26. Cuff Leak Test for the Diagnosis of Post-Extubation Stridor: A Multicenter Evaluation Study. J Intensive Care Med. 2019 May; 34(5):391-396.
    View in: PubMed
    Score: 0.001
  27. Hypothermia for Neuroprotection in Convulsive Status Epilepticus. N Engl J Med. 2016 12 22; 375(25):2457-2467.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.